JFL Life Sciences Limited IPO Message Board (Page 8)

What do you mean by two retail sme?
Do you mean two seperate retails applications with 1 lot each?
Or
One application with two lots? As retail, you can apply one lot, anything more than one lot you will come under HNI.

Two separate applications

No doubt GLS is one of the leading manufacturers of Pharmaceutical ingredients, but what is the outcome for investors.52 weak high is 726 against issue price of 720. Latest 440.50. All figures of BSE. When an investor has loss of 40% on investment, what to do. What is the intention of promoters. Do they think something about investors. See the share price of Glenmerk Pharmaceutical. At the time of IPO it was very high. All this factors matter. All that glitter is not gold. You may buy as many shares of GLS. That's your way of thinking.
All the best.

Dear PKRAJ
At the time of LIC ipo I have written in this forum, that the valuations of LIC IPO price is too high as compared to the listed peers of it. However many investors have opposed and not agree with my view. Any one can agree or disagree with anyone's view, it's upto them. Now one can watch the LIC where it stands. In this era everything is managed by funds.

My view is that when Leader GLS is trading @ 12.6 but this new pharma company is entering in the market is offering much much higher valuations. One may think this point if he loves his money. That's all.

People lost faith from GLS after promoters removed shareholder quota in RHP.

@Maria
When a Group like Glenmerk has not thought about retail investors, we must thin many times to apply in such SMEs. It's better not to discuss PSUs, Seldom friendly to the investors. But never learned any lesson.
@Tesonaj
We should than thank GLS for removal of shareholders quota, otherwise more losses: in GLS and GPL purchased for applying in shareholders quota. It is all for the best if I am not wrong.
Hope for better profits.

I am not favouring the GLS. W h en you say that GLS is market leader in this field then obviously the other company's value may be lesser than the newer one. The new company is still long to go and prove it's credibility. I don't have the GLS in my portfolio but in the 90s Glenmark Pharma have given me a wonderful wonderful returns in past. My intention is just to bring the facts to the new comers and decide by the facts of Valuation of the company which is offering. I am not favoring or opposing just give the valuation facts in the forum. Money is yours hence decision is always your but don't say that no one have highlighted this fact.

To be very frank...
Glenmark Pharma and Glenmark Life Sciences are having excellent brand value, High Quality, Strict GMP adherence, Many Stringent Regulatory Approvals (USFDA, EUGMP, PMDA), Very good Regulatory team for global product registration filings, CMO contracts with abroad companies, MA holder (Dossier registrations as a Sponsor company for many of its client abroad companies),.. More than anything, Quality of products is Top notch and it is a Trusted supplier for its clients including Patients, Complex formulations, Complex API molecules, Continuous aggressive expansion of manufacturing capacities, Most nice segment Oncology sector (min. 30% margins will workout), If I have to tell like this merits about Glenmark as a Pharmaceutical company / API producer, I should keep writing whole day.....

Finally in Quality / Technology / Brand value front, I give 5 star rating in 1 to 5 Scale...

but when it comes to the Investors front, it is 1star group out of 1 to 5 scale. This I am not giving, large public has assigned due to various reasons..... of no wealth appreciation, Least investor friendly management etc. etc....

Well mumy neighbour works in Glenmark and he says, do not invest in Glenmark. Books are manipulated and insider trading is huge. Pharmaceutical cartel is bigger than we think. Better to stay away.

@Userrrr

I have no account in Upstox. But recently I have heard that it allows to Trade in SME ipo from the very first day of Listing.

No issue in upstox in Asba